RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns

Autor: Dubreuil, M., Walsh, J.A, Deodhar, A., Gensler, L.S, Curtis, J.R, Anjohrin, S., Pilipczuk, O., Feudjo Tepie, M., Beaty, S., Mørup, M., Taieb, V., Welby, S.
Zdroj: In Value in Health June 2023 26(6) Supplement:S386-S387
Databáze: ScienceDirect